Predict your next investment

MODAG company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Series A | Alive

Total Raised


Last Raised

$13.64M | 3 yrs ago


MODAG is a German biotech company that aims to provide an approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools.

MODAG Headquarter Location

Mikroforum Ring 3

Wendelsheim, 55234,



Latest MODAG News

MODAG’s Collaboration Agreement with Teva

Nov 10, 2021

Baker McKenzie advised Modag GmbH on the deal. MODAG GmbH signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. on the exclusive worldwide licensing and development of MODAG’s […]

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MODAG

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MODAG is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

15,532 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

MODAG Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo


CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.